Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: Results from the REDUCE study
Publisher: John Wiley & Sons Inc
E-ISSN: 1097-0142|120|2|190-196
ISSN: 0008-543x
Source: CANCER, Vol.120, Iss.2, 2014-01, pp. : 190-196
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract